Skip to main content
Clinical Trials/ISRCTN15670031
ISRCTN15670031
Completed
N/A

A new non-invasive diagnostic method for detection of pathogenic mitochondrial DNA variants using faecal-derived DNA samples

ewcastle upon Tyne Hospitals NHS Foundation Trust0 sites47 target enrollmentMay 16, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust
Enrollment
47
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 16, 2022
End Date
October 31, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. A genetically confirmed diagnosis of mitochondrial disease, specifically, the common m.3243A\> G variant.
  • 2\. Adults aged \>\=16 years old
  • 3\. Paediatrics aged \<16 years old
  • 4\. Have ability, in the opinion of the recruiting investigator to undergo all study assessments and investigations.
  • 5\. Capable of providing informed consent

Exclusion Criteria

  • 1\. Currently have a confirmed bowel obstruction
  • 2\. Received surgery on the gastrointestinal tract in last 12 months
  • 3\. New drug regime within the 3 months prior to providing a faecal sample
  • 4\. Participating in any study that may influence the gastrointestinal tract three months prior to study commencement.

Outcomes

Primary Outcomes

Not specified

Similar Trials